About Bioavlee
Bioavlee is a Healthcare company based in Wrocław (Poland) founded in 2014. Bacteria are identified rapidly using laser diffraction and neural networks. Bioavlee has raised $536.43 thousand across 1 funding round. The company has 3 employees. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Imaging Systems.
Company details
Bioavlee was founded in 2014 in Wroclaw, Poland, within the biotech sector. A proprietary platform is commercialized for bacteria identification, relying on laser diffraction patterns, algorithms, neural networks, and big data. Samples are analyzed for bacteria grown on standard media, with identification completed in 9-16 hours at 98 accuracy. A large database of diffraction patterns from various bacterial species is maintained to support the process.
- Headquarters Wrocław, Poland
- Employees 3
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bioavlee.com
- Annual Revenue$19.7 K (USD)-58as on Dec 31, 2022
- Net Profit-$61.16 K (USD)-351as on Dec 31, 2022
- EBITDA-$61.1 K (USD)-335as on Dec 31, 2022
- Total Equity Funding$536.43K (USD)
in 1 rounds
- Latest Funding Round$536.43K (USD), Seed
Sep 2018
- Employee Count3
Funding Insights of Bioavlee
Bioavlee has successfully raised a total of $536.43K through 1 strategic funding round. The most recent funding activity was a Seed round of $536.43 thousand completed in September 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $536,432
- Total Rounds 1
- Last Round Seed — $536,432
- First Round $536,432
(Sep 2018)
All 1 funding rounds of Bioavlee with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2018 | $536,432 | Seed | – | – | – |
Timeline of Bioavlee
2 dated milestones of Bioavlee across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Bioavlee is founded.
- Funding First funding round of $536K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bioavlee
Bioavlee was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Bioavlee is headquartered in Wrocław, Poland. It is registered at Wrocław, Lower Silesian Voivodeship, Poland.
Bioavlee is a funded company, having raised a total of $536.43K across 1 funding round to date. The company's 1st funding round was a Seed of $536.43K, raised on Sep 2018.
Bioavlee has 3 employees.
Annual revenue of Bioavlee is $19.7K as on Dec 31, 2022.
Bioavlee was founded in 2014 in Wroclaw, Poland, within the biotech sector. A proprietary platform is commercialized for bacteria identification, relying on laser diffraction patterns, algorithms, neural networks, and big data. Samples are analyzed for bacteria grown on standard media, with identification completed in 9-16 hours at 98 accuracy. A large database of diffraction patterns from various bacterial species is maintained to support the process.